Skip to main content
SpringerLink
Log in

Synthesis Characterization and In Vitro Release Study of Ciprofloxacin-Loaded Chitosan Nanoparticle

  • Published:
BioNanoScience Aims and scope Submit manuscript

Abstract

Ciprofloxacin, a poorly soluble drug-loaded chitosan nanoparticle, was prepared for the treatment of microbial infections. Nanoformulation of ciprofloxacin was prepared using 85% deacetylated chitosan as a biodegradable polymer and tripolyphosphate (TPP) as a cross-linking agent by ionotropic gelation. It was further evaluated and characterized on the basis of morphology, drug loading efficiency, X-ray diffraction, zeta potential value, Fourier transform infrared study, antimicrobial study, and also in vitro release behavior of ciprofloxacin. The FTIR spectral studies indicated that there was no interaction found between the drug and chitosan. The sample CS1 formulation was found stable with good drug entrapment efficiency, fair zeta potential value, and its size ranged between 100 and 200 nm. The in vitro study showed sustained release behavior with steady rise in cumulative drug release (> 99%) for up to about 8 h and thereafter, no significant release observed. The characterized formulations were also used to study antimicrobial activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Wu, G., Wang, G., Fu, X., & Zhu, L. (2003). Synthesis, crystal structure, stacking effect and antimicrobial studies of novel quaternary copper (II) complex with quinolone. Molecules, 8, 287–296.

    Article  Google Scholar 

  2. LG, S., & WN, K. (1997). Development of ciprofloxacin: the USA perspective. In W. APR & R. N. Gruneberg (Eds.), Ciprofloxacin: 10 years of clinical experiences (pp. 1–5). Oxford: Published by Maxim Medical.

    Google Scholar 

  3. British Pharmacopia (BP). (2009). (493). London: The stationary office; 493.

  4. Blondeau, J. M. (2004). Fluoroquinolones: Mechanism of action, classification, and development of resistance. Survey of Ophthalmology, 49(2), S73–S78.

    Article  Google Scholar 

  5. Wilhelmus, K. R., Hyndiuk, R. A., Caldwell, D. R., Abshire, R. L., Folkens, A. T., & Godio, L. B. (1993). 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The ciprofloxacin ointment/bacterial keratitis study group. Archives of Ophthalmology, 11, 1210–1218.

    Article  Google Scholar 

  6. Acar, J. F., & Goldstein, F. W. (1997). Trends in bacterial resistance to fluoroquinolones. Clinical Infectious Diseases, 24(1), S67–S73.

    Article  Google Scholar 

  7. Huneault, L. M., Lussier, B., Dubreuil, P., Chouinard, L., & Désévaux, C. (2004). Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants. Journal of Orthopaedic Research, 22(6), 1351–1357.

    Article  Google Scholar 

  8. Mehnert, W., & Mader, K. (2001). Solid lipid nanoparticles: production, characterization and applications. Advanced Drug Delivery Reviews, 47(2–3), 165–196.

    Article  Google Scholar 

  9. McCarron, P. A., & Hall, M. (2008). International Journal of Pharmaceutics, 348, 115–124.

    Article  Google Scholar 

  10. Goya, S., Rai, J. K., Narang, R. K., & Rajesh, K. S. (2010). International Journal of Pharmacy and Pharmaceutical Sciences, 2(2), 1–6.

    Google Scholar 

  11. Gunatillake, P. A., & Adhikari, R. (2003). European Cells and Materials, 5, 1–16.

    Article  Google Scholar 

  12. Lam, X. M., Duenas, E. T., Daugherty, A. L., Levin, N., & Cleland, J. L. (2000). Journal of Controlled Release, 67, 281–292.

    Article  Google Scholar 

  13. Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., & Langer, R. (1991). Pharmaceutical Research, 8, 713–720.

    Article  Google Scholar 

  14. Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001). Chitosan and its derivatives as intestinal absorption enhancers. Advanced Drug Delivery Reviews 50 Suppl, 1, S 91–S101.

    Article  Google Scholar 

  15. Suri, S. S., Fenniri, H., & Singh, B. (2007). Nanotechnology-based drug delivery systems. Journal of Occupational Medicine and Toxicology, 2, 1–6. https://doi.org/10.1186/1745- 6673-2-1.

    Article  Google Scholar 

  16. Calvo, P., Remuan-Lopez, C., Vila-Jato, J., & Alonso, M. (1997). Journal of Applied Polymer Science, 125132, 63.

    Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the financial support from the Department of Science & Technology-INSPIRE fellowship, New Delhi, India. Prof. R.K.Mandal (Department of Metallurgical Engineering, IIT, BHU, Varanasi) for providing SEM facility, CISF, IIT,BHU for providing XRD facility & S.K. Singh (Department of pharmaceutics, IIT, BHU, VARANASI) for providing zeta potential and FTIR facility.

Author information

Authors and Affiliations

  1. School of Biochemical Engineering, Indian Institute of Technology, Banaras Hindu University, Varanasi, India

    Kushagri Singh & Abha Mishra

  2. Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

    Amit Singh

Authors
  1. Kushagri Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abha Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amit Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abha Mishra.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, K., Mishra, A. & Singh, A. Synthesis Characterization and In Vitro Release Study of Ciprofloxacin-Loaded Chitosan Nanoparticle. BioNanoSci. 8, 229–236 (2018). https://doi.org/10.1007/s12668-017-0470-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12668-017-0470-7

Keywords

Search

Navigation